Eight healthcare executives discussed their views on the JPM Healthcare Conference 2024. Topics included the importance of the conference for attracting investors, a sense of optimism in capital markets, the need for workforce intelligence in healthcare systems, partnerships with large pharmaceutical companies, and the importance of AI in drug discovery. Additionally, women’s health, M&A activity in pharma, patient-centricity in geo-political situations, combating obesity, automation in healthcare, and using in-silico approaches in drug development were discussed.
Recursion, Roche Unveil Microglia Map of Neuro Disease Targets
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of
